JS, T., LB, A., MS, S., CE, M., R, P., T, S., & BJ, G. (2021). Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody. Virology, 558, 28. https://doi.org/10.1016/j.virol.2021.01.003
Chicago Style (17th ed.) CitationJS, Terry, Anderson LB, Scherman MS, McAlister CE, Perera R, Schountz T, and Geiss BJ. "Development of a SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibody." Virology 558 (2021): 28. https://doi.org/10.1016/j.virol.2021.01.003.
MLA (9th ed.) CitationJS, Terry, et al. "Development of a SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibody." Virology, vol. 558, 2021, p. 28, https://doi.org/10.1016/j.virol.2021.01.003.
Warning: These citations may not always be 100% accurate.